Sugi Predict

Sugi Predict / Compounds / SCHEMBL4436178

SCHEMBL4436178

SCHEMBL4436178

Cc1cc(C)cc(-c2ccc3c(C)cccc3n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ THRB P10828 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ CYP2A6 P11509 1/20 0.39
▸ PTGER4 P35408 1/20 0.39
▸ PDE3B Q13370 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ PDE10A Q9Y233 1/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ AR P10275 3/20 0.38
▸ ADORA2A P29274 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ PSMB5 P28074 1/20 0.37
▸ NR1I3 Q14994 1/20 0.37
▸ NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29531209 1.00 CYP1A2 (0.43) CYP1A2ALDH1A1MAPTTDP1THRB
SCHEMBL20809054 0.88 BCHE (0.47) CYP1A2ALDH1A1MAPTTDP1THRB
SCHEMBL31058808 0.87 BCHE (0.46) CYP1A2ALDH1A1MAPTTDP1THRB
SCHEMBL29262959 0.87 BCHE (0.46) CYP1A2ALDH1A1MAPTTDP1THRB
SCHEMBL18876531 0.84 RAB9A (0.50) CYP1A2ALDH1A1MAPTTDP1THRB
SCHEMBL12486646 0.83 BACE1 (0.49) CYP1A2ALDH1A1MAPTTDP1BACE1
SCHEMBL30052647 0.83 BACE1 (0.49) CYP1A2ALDH1A1MAPTTDP1BACE1
SCHEMBL29769817 0.83 AR (0.40) ALDH1A1MAPTTDP1PDE3BPDE3A
SCHEMBL10318960 0.83 AR (0.40) ALDH1A1MAPTTDP1PDE3BPDE3A
SCHEMBL10078860 0.83 MBNL1 (0.36) TDP1THRBPDE10AKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114478638-B Compound containing 1, 3-diketone ligand, application thereof and organic electroluminescent device 北京绿人科技有限责任公司 2024-03-15 — — CN disclosed
CN-114478639-B Compound containing 1, 3-diketone ligand, application thereof and organic electroluminescent device 北京绿人科技有限责任公司 2024-03-12 — — CN disclosed
US-20230382935-A1 COMPOUND CONTAINING 1,3-DIKETONE LIGAND AND APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE BEIJING GREEN GUARDEE TECHNOLOGY CO., LTD. (CN) 2023-11-30 — — US disclosed
US-20230382935-A1 COMPOUND CONTAINING 1,3-DIKETONE LIGAND AND APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE BEIJING GREEN GUARDEE TECHNOLOGY CO., LTD. (CN) 2023-11-30 — — US disclosed
US-20230382935-A1 COMPOUND CONTAINING 1,3-DIKETONE LIGAND AND APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE BEIJING GREEN GUARDEE TECHNOLOGY CO., LTD. (CN) 2023-11-30 — — US disclosed
CN-114478640-B Compound containing 1, 3-diketone ligand, application thereof and organic electroluminescent device 北京绿人科技有限责任公司 2023-10-24 — — CN disclosed
CN-114478641-B Compound containing 1, 3-diketone ligand, application thereof and organic electroluminescent device 北京绿人科技有限责任公司 2023-09-05 — — CN disclosed
WO-2023082897-A1 METAL IRIDIUM COMPLEX AND APPLICATION THEREOF 广东阿格蕾雅光电材料有限公司 2023-05-19 — — WO disclosed
WO-2022267941-A1 ORGANOMETALLIC IRIDIUM COMPOUND 广东阿格蕾雅光电材料有限公司 2022-12-29 — — WO disclosed
WO-2022262309-A1 ORGANOMETALLIC IRIDIUM COMPOUND AND APPLICATION THEREOF 广东阿格蕾雅光电材料有限公司 2022-12-22 — — WO disclosed
EP-2489716-A2 Phosphorescent materials Universal Display Corporation (US) 2012-08-22 — — EP disclosed
EP-2489716-A2 Phosphorescent materials Universal Display Corporation (US) 2012-08-22 — — EP disclosed
EP-2465912-A1 Phosphorescent Materials Universal Display Corporation (US) 2012-06-20 — — EP disclosed
EP-2465912-A1 Phosphorescent Materials Universal Display Corporation (US) 2012-06-20 — — EP disclosed
EP-2121871-A2 PHOSPHORESCENT MATERIALS University Display Corporation (US) 2009-11-25 — — EP disclosed
US-20080261076-A1 Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility UNIVERSAL DISPLAY CORPORATION (US) 2008-10-23 — — US disclosed
US-20080261076-A1 Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility UNIVERSAL DISPLAY CORPORATION (US) 2008-10-23 — — US disclosed
US-20080261076-A1 Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility UNIVERSAL DISPLAY CORPORATION (US) 2008-10-23 — — US disclosed
WO-2008109824-A2 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2008-09-12 — — WO disclosed
WO-2008109824-A2 PHOSPHORESCENT MATERIALS UNIVERSAL DISPLAY CORPORATION (US) 2008-09-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261076-A1 Substituted 2-Phenyl quinoline complex with Iridium; high device efficiency, stability, and processibility PCID2, ICMT, ORAI2 CYP1A2 1511/4885ALDH1A1 3830/4885MAPT 1465/4885
US-20230382935-A1 COMPOUND CONTAINING 1,3-DIKETONE LIGAND AND APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE TLK1, TLK2, PDK3 CYP1A2 4408/4885ALDH1A1 963/4885MAPT 3063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.